Vigilant Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-197,440
| Closed | -$8.93M | – | 623 |
|
|
2022
Q2 | $8.93M | Buy |
197,440
+120,257
| +156% | +$5.44M | 0.77% | 45 |
|
|
2022
Q1 | $5.87M | Buy |
77,183
+5,946
| +8% | +$452K | 0.45% | 46 |
|
|
2021
Q4 | $10.6M | Buy |
71,237
+7,749
| +12% | +$1.15M | 0.74% | 46 |
|
|
2021
Q3 | $9.24M | Buy |
63,488
+1,461
| +2% | +$213K | 0.74% | 48 |
|
|
2021
Q2 | $12.1M | Buy |
62,027
+4,437
| +8% | +$869K | 0.98% | 46 |
|
|
2021
Q1 | $10.4M | Buy |
+57,590
| New | +$10.4M | 0.93% | 46 |
|